Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immune-related Adverse Event × Other hematologic neoplasm × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 348 Precursor Cell Lymphoblastic Leukemia-Lymphoma 196 Leukemia, Lymphocytic, Chronic, B-Cell 171 Hematologic Neoplasms 169 Myelodysplastic Syndromes 124 Leukemia 123 Lymphoma 78 Lymphoma, Non-Hodgkin 69 Leukemia, Myelomonocytic, Chronic 53 Multiple Myeloma 47 Recurrence 45 Neoplasms 45 Lymphoma, Large B-Cell, Diffuse 45 Burkitt Lymphoma 44 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 43 Lymphoma, Mantle-Cell 38 Lymphoma, Follicular 36 Leukemia, Biphenotypic, Acute 36 Lymphoma, B-Cell, Marginal Zone 32 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31 Myeloproliferative Disorders 30 Lymphoma, B-Cell 30 Hodgkin Disease 27 Waldenstrom Macroglobulinemia 20 Leukemia, B-Cell 19 Primary Myelofibrosis 18 Anemia, Refractory, with Excess of Blasts 17 Hematologic Diseases 16 Leukemia, Myeloid, Chronic-Phase 15 Myelodysplastic-Myeloproliferative Diseases 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡